TY  - JOUR
AU  - Pascual-Figal, Domingo A
AU  - Zamorano, J Luis
AU  - Domingo, Mar
AU  - Morillas, Herminio
AU  - Nuñez, Julio
AU  - Cobo Marcos, Marta
AU  - Riquelme-Pérez, Alejandro
AU  - Teis, Albert
AU  - Santas, Enrique
AU  - Caro-Martinez, Cesar
AU  - Pinilla, Jose Manuel
AU  - Rodriguez-Palomares, Jose F
AU  - Dobarro, David
AU  - Restrepo-Córdoba, M Alejandra
AU  - González-Juanatey, J Ramón
AU  - Bayés Genís, Antoni
PY  - 2023
DO  - 10.1002/ejhf.2884
UR  - http://hdl.handle.net/20.500.12105/16414
AB  - AIMSDapagliflozin improves the prognosis of patients with heart failure (HF), regardless of left ventricular ejection fraction (LVEF). However, its effect on cardiac remodelling parameters, specifically left atrial (LA) remodelling, is not well...
LA  - eng
PB  - Wiley
KW  - Heart Failure
KW  - Humans
KW  - Ventricular Function, Left
KW  - Stroke Volume
KW  - Prospective Studies
KW  - Ventricular Remodeling
TI  - Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: The DAPA-MODA study.
TY  - journal article
ER  -